Search clinical trials for: Naltrexone 25 Mg Inactive Marijuana (0% THC)

Total 262 results

New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene...

Completed

Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana

Marijuana Use
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene...

Completed

Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana

Marijuana Smoking

United States
Timothy L. Brown
National Highway Traffic Safety Administration (NHTSA); Cognitive Research... and other collaborators

Completed

Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim (PDID)

Driving Under the Influence | Driving Behavior

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effects of Smoked Marijuana on Risk Taking and Decision Making Tasks

Marijuana Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene...

Completed

Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers

Mood | Pain Threshold

United States
University of California, San Diego
Center for Medicinal Cannabis Research

Recruiting

Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity

HIV | Cannabis Use

United States
Gary R Gaffney
National Institute on Drug Abuse (NIDA); National Highway Traffic Safety Administration...

Completed

Effects of Inhaled Cannabis on Driving Performance

Alcohol Drinking | Cannabis

United States
Advanced Brain Monitoring, Inc.
University of Iowa

Completed

Cannabis Impairment Detection Application (CIDA) (CIDA)

Alcohol Intoxication | Driving Under the Influence | Marijuana Intoxication

United States
Yale University
National Institute on Drug Abuse (NIDA); Hartford Hospital; National Highway...

Active, not recruiting

Examine the Feasibility of a Standardized Field Test for Marijuana and Alcohol Impairment: Laboratory Evaluations (Alc-NHTSA)

Alcohol Impairment | Marijuana Impairment

United States
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Completed

Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Healthy Subjects

Infection, Human Immunodeficiency Virus

United States
Alkermes, Inc.

Completed

ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent Adults

Alcoholism
University of California, San Francisco

Completed

A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone

Multiple Sclerosis

United States
Alkermes, Inc.

Terminated

ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])

Alcoholism | Opiate Dependence
Alkermes, Inc.

Completed

ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®)

Alcoholism
Alkermes, Inc.

Completed

ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults

Alcoholism
Alkermes, Inc.

Completed

ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids

Opiate Dependence
Alkermes, Inc.

Completed

ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®)

Alcohol Dependence
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Completed

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)

HIV Infections

Germany, Spain, United States, Canada, Taiwan, France, Italy, Argentina, United Kingdom, Russian Federation, Australia
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Completed

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)

HIV Infections

Germany, Taiwan, France, United States, Canada, Belgium, Australia, Netherlands, Spain, United Kingdom, Italy, Argentina, Russian Federation
Fundacion Clinic per a la Recerca Biomédica

Active, not recruiting

Safety, Tolerability, and Efficacy of a Dose Reduction Strategy Based on Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-infected Adults (BETAF-RED)

HIV Infections

Spain
Neurotune AG

Unknown

Dimiracetam in Painful Neuropathies Affecting AIDS Patients (DIPANAP)

Acquired Immunodeficiency Syndrome

Switzerland
GlaxoSmithKline

Completed

Tucaresol As Add-On To HAART (Highly Active Antiretroviral Therapy) In Chronic HIV-1 Infected Adults

HIV Infection

Italy
Alkermes, Inc.

Completed

ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals

Opiate Dependence

United States
Boston University

Completed

Safety and Effect of Doxycycline in Patients With Amyloidosis

Amyloidosis

United States
Clinical Nutrition Research Center, Illinois Institute...

Completed

Dose-dependent Effect of Grape Seed Extract on Glucose Control in People With Impaired Glucose Tolerance (GSE3)

Impaired Glucose Tolerance

United States
Alkermes, Inc.

Completed

ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced Abstinence

Alcohol Dependence
United BioPharma
National Taiwan University Hospital; Kaohsiung Medical University Chung-Ho... and other collaborators

Completed

The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients

HIV-1 Infection

Taiwan
UBP Greater China (Shanghai) Co., Ltd

Not yet recruiting

The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients (HIV-1)

HIV-1-infection
Pharmtechnology LLC
Ligand Research, LLC

Completed

Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Centre for Addiction and Mental Health

Unknown

Vivitrol Treatment for Cannabis Use Disorder

Cannabis Use Disorder

Canada
VA Office of Research and Development

Completed

N-acetylcysteine Plus Naltrexone for the Treatment of Alcohol Dependence

Alcoholism

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Modafinil for Smoked Cocaine Self-Administration

Cocaine Dependence

United States
Alkermes, Inc.

Completed

ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence

Opiate Dependence

Russian Federation
Alkermes, Inc.

Completed

ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults

Alcohol Dependence

United States
State University of New York - Upstate Medical...

Completed

Participant(s) With Autism and High Pain Tolerance Treated With High Dose Naltrexone

Autism Spectrum Disorder

United States
Merck Sharp & Dohme LLC

Completed

A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy (MK-0859-021)

Hypercholesterolemia
Go Medical Industries Pty Ltd
National Institute on Drug Abuse (NIDA); Columbia University; New York State... and other collaborators

Completed

Pharmacokinetic Study of Vivitrol in Healthy Participants

Opioid-use Disorder

United States
Chulalongkorn University

Recruiting

Pharmacokinetics, Safety, and Efficacy of Dolutegravir Dispersible Tablets in Young Children Living With HIV

Pediatric HIV Infection

Thailand
University of Pennsylvania

Completed

CURE Addiction Center of Excellence: Brain Mechanisms of Relapse and Recovery (fMRI CURE)

Prescription Opiate/Medication Dependence

United States
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism

Alcohol Dependence

United States
Janssen Research & Development, LLC

Withdrawn

A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Odalasvir and AL-335 Alone and in Combination With Simeprevir in Participants With Moderately Impaired Hepatic Function

Hepatic Impairment
Otsuka Pharmaceutical Development & Commercialization...

Completed

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Pediatric | Multidrug Resistant Tuberculosis

Philippines, South Africa
Weill Medical College of Cornell University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

Naltrexone Treatment for Prolonged Grief Disorder (PGD) (PGD)

Prolonged Grief Disorder

United States
Assiut University

Not yet recruiting

Psychiatric Disorders Related to Diabetes Mellitus Type 1 Among Children in Egypt

Adolescents | Psychiatric Disorders | Diabetes Mellitus Type 1
Xhale Assurance
National Institute on Drug Abuse (NIDA)

Completed

An Adherence Tool to Manage Narcotic -Addicted HIV Patients

Healthy Adults

United States
Boehringer Ingelheim
Eli Lilly and Company

Completed

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Japan
Boehringer Ingelheim

Completed

A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients

Hypertension

United States
Omar Tarek Elfarargi

Not yet recruiting

Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease (SGLT2i VS ACEi)

Diabetic Nephropathy Type 2
University of Missouri-Columbia

Completed

Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation

Constipation Drug Induced

United States
Usona Institute
Worldwide Clinical Trials

Recruiting

Psilocybin for Major Depressive Disorder (MDD) (uAspire)

Depressive Disorder, Major

United States

Search clinical trials for: Naltrexone 25 Mg Inactive Marijuana (0% THC)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations